{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T20:57:43Z","timestamp":1785531463932,"version":"3.56.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["advancesradonc.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Radiation Oncology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.adro.2026.102122","type":"journal-article","created":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T05:27:36Z","timestamp":1782019656000},"page":"102122","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of Consolidation-to-Tumor Ratio on Prognosis After Radiation therapy for Lung Cancer With a Lesion Diameter of 3 cm or Less"],"prefix":"10.1016","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4431-8892","authenticated-orcid":false,"given":"Masaki","family":"Nakamura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidenari","family":"Hirata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Hiroshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Makita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromi","family":"Baba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Someya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Mukohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadamoto","family":"Zenda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.adro.2026.102122_bib0001","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.chest.2025.06.023","article-title":"Management of patients with early-stage non-small cell lung cancer: An American College of Chest Physicians clinical practice guideline","volume":"168","author":"Howington","year":"2025","journal-title":"Chest"},{"key":"10.1016\/j.adro.2026.102122_bib0002","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1200\/OP.22.00475","article-title":"Stereotactic body radiotherapy for the management of early-stage non-small-cell lung cancer: A clinical overview","volume":"19","author":"Buchberger","year":"2023","journal-title":"JCO Oncol Pract"},{"key":"10.1016\/j.adro.2026.102122_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2025.110868","article-title":"Clinical outcomes of proton beam therapy for inoperable stage I-IIA non-small cell lung cancer: Japanese nationwide registry study","volume":"207","author":"Nakamura","year":"2025","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.adro.2026.102122_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2024.110385","article-title":"Proton and carbon ion radiotherapy for operable early-stage lung cancer; A prospective nationwide registry","volume":"198","author":"Harada","year":"2024","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.adro.2026.102122_bib0005","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jtho.2015.09.009","article-title":"The IASLC lung cancer staging project: Proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung cancer","volume":"11","author":"Goldstraw","year":"2016","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.adro.2026.102122_bib0006","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.jtho.2024.02.011","article-title":"The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for revision of the TNM stage groups in the forthcoming (ninth) edition of the TNM classification for lung cancer","volume":"19","author":"Rami-Porta","year":"2024","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.adro.2026.102122_bib0007","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/S0140-6736(21)02333-3","article-title":"Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802\/WJOG4607L): A multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial","volume":"399","author":"Saji","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.adro.2026.102122_bib0008","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/S2213-2600(23)00041-3","article-title":"Segmentectomy for ground-glass-dominant lung cancer with a tumour diameter of 3 cm or less including ground-glass opacity (JCOG1211): A multicentre, single-arm, confirmatory, phase 3 trial","volume":"11","author":"Aokage","year":"2023","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.adro.2026.102122_bib0009","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.lungcan.2015.12.003","article-title":"Relationship between the consolidation to maximum tumor diameter ratio and outcomes following stereotactic body radiotherapy for stage I non-small-cell lung cancer","volume":"92","author":"Tsurugai","year":"2016","journal-title":"Lung Cancer"},{"key":"10.1016\/j.adro.2026.102122_bib0010","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/ajco.14194","article-title":"Treatment outcomes of stereotactic body radiotherapy for ground glass opacity nodules and solid lung cancer","volume":"22","author":"Hamamoto","year":"2026","journal-title":"Asia Pac J Clin Oncol"},{"key":"10.1016\/j.adro.2026.102122_bib0011","doi-asserted-by":"crossref","DOI":"10.1111\/1759-7714.70110","article-title":"Prognostic impact of tumor solid components in stereotactic body radiotherapy for clinical stage Tis-1N0M0 lung cancer","volume":"16","author":"Fukuda","year":"2025","journal-title":"Thorac Cancer"},{"key":"10.1016\/j.adro.2026.102122_bib0012","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.cllc.2025.09.013","article-title":"Tumor-agnostic circulating tumor DNA analysis as a comprehensive predictive biomarker of recurrence after ablative radiotherapy for early-stage non-small cell lung cancer","volume":"26","author":"Nakamura","year":"2025","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.adro.2026.102122_bib0013","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S2213-2600(23)00382-X","article-title":"Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer with radiologically pure-solid appearance in Japan (JCOG0802\/WJOG4607L): A post-hoc supplemental analysis of a multicentre, open-label, phase 3 trial","volume":"12","author":"Hattori","year":"2024","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.adro.2026.102122_bib0014","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ijrobp.2019.09.037","article-title":"Predicting 5-year progression and survival outcomes for early stage non-small cell lung cancer treated with stereotactic ablative radiation therapy: Development and validation of robust prognostic nomograms","volume":"106","author":"Kang","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2026.102122_bib0015","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.jtho.2022.11.007","article-title":"Prediction of distant metastases after stereotactic body radiation therapy for early stage NSCLC: Development and external validation of a multi-institutional model","volume":"18","author":"Gao","year":"2023","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.adro.2026.102122_bib0016","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.jtho.2017.11.129","article-title":"Influence of ground glass opacity and the corresponding pathological findings on survival in patients with clinical stage I non-small cell lung cancer","volume":"13","author":"Aokage","year":"2018","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.adro.2026.102122_bib0017","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.rmed.2017.06.015","article-title":"A clinicopathological study of surgically resected lung cancer in patients with usual interstitial pneumonia","volume":"129","author":"Watanabe","year":"2017","journal-title":"Respir Med"},{"key":"10.1016\/j.adro.2026.102122_bib0018","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1093\/jrr\/rraa015","article-title":"Stereotactic body radiotherapy in patients with lung tumors composed of mainly ground-glass opacity","volume":"61","author":"Onishi","year":"2020","journal-title":"J Radiat Res"},{"key":"10.1016\/j.adro.2026.102122_bib0019","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1200\/JCO-25-00610","article-title":"Phase III study of mediastinal lymph node dissection for ground glass opacity-dominant lung adenocarcinoma","volume":"43","author":"Zhang","year":"2025","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.adro.2026.102122_bib0020","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1093\/jjco\/hyab074","article-title":"Prospective evaluation of watchful waiting for early-stage lung cancer with ground-glass opacity: A single-arm confirmatory multicenter study: Japan Clinical Oncology Group study JCOG1906 (EVERGREEN study)","volume":"51","author":"Miyoshi","year":"2021","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.adro.2026.102122_bib0021","first-page":"277","volume":"47","author":"Kimura","year":"2017","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.adro.2026.102122_bib0022","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1200\/JCO.21.01611","article-title":"Inoperable early-stage non-small-cell lung cancer: Stereotactic ablative radiotherapy and rationale for systemic therapy","volume":"40","author":"Daly","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.adro.2026.102122_bib0023","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1001\/jama.2010.261","article-title":"Stereotactic body radiation therapy for inoperable early stage lung cancer","volume":"303","author":"Timmerman","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.adro.2026.102122_bib0024","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.ijrobp.2015.07.2278","article-title":"Prospective trial of stereotactic body radiation therapy for both operable and inoperable T1N0M0 non-small cell lung cancer: Japan Clinical Oncology Group study JCOG0403","volume":"93","author":"Nagata","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2026.102122_bib0025","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.jtho.2016.03.025","article-title":"The IASLC lung cancer staging project: Proposals for coding T categories for subsolid nodules and assessment of tumor size in part-solid tumors in the forthcoming eighth edition of the TNM classification of lung cancer","volume":"11","author":"Travis","year":"2016","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.adro.2026.102122_bib0026","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.2214\/ajr.178.5.1781053","article-title":"CT screening for lung cancer: Frequency and significance of part-solid and nonsolid nodules","volume":"178","author":"Henschke","year":"2002","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.adro.2026.102122_bib0027","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1056\/NEJMoa1214726","article-title":"Probability of cancer in pulmonary nodules detected on first screening CT","volume":"369","author":"McWilliams","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.adro.2026.102122_bib0028","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s40364-024-00642-5","article-title":"Comparison of proton therapy and photon therapy for early-stage non-small cell lung cancer: A meta-analysis","volume":"12","author":"He","year":"2024","journal-title":"Biomark Res"}],"container-title":["Advances in Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452109426001296?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452109426001296?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T09:18:55Z","timestamp":1784107135000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452109426001296"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":28,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S2452109426001296"],"URL":"https:\/\/doi.org\/10.1016\/j.adro.2026.102122","relation":{},"ISSN":["2452-1094"],"issn-type":[{"value":"2452-1094","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of Consolidation-to-Tumor Ratio on Prognosis After Radiation therapy for Lung Cancer With a Lesion Diameter of 3 cm or Less","name":"articletitle","label":"Article Title"},{"value":"Advances in Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.adro.2026.102122","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of American Society for Radiation Oncology.","name":"copyright","label":"Copyright"}],"article-number":"102122"}}